Skip to content
healthcare.dev

CEO-TWO

NDC 0283-1023, Laxative, suppository, from Beutlich Pharmaceuticals, LLC.

Product NDC
0283-1023
Status
Listed
Labeler
Beutlich Pharmaceuticals, LLC
Dosage form
SUPPOSITORY
Route
RECTAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M007
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0283-1023 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • POTASSIUM BITARTRATE.9 g/5.7g
  • SODIUM BICARBONATE.6 g/5.7g

Pharmacologic classes

Alkalinizing Activity [MoA]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Potassium Compounds [CS]; Potassium Salt [EPC]

Package NDCNDC-11Package
0283-1023-02002831023022 DOSE PACK in 1 BOX (0283-1023-02) / 5.7 g in 1 DOSE PACK (0283-1023-00)
0283-1023-36002831023366 DOSE PACK in 1 BOX (0283-1023-36) / 5.7 g in 1 DOSE PACK (0283-1023-00)
0283-1023-540028310235454 DOSE PACK in 1 BOX (0283-1023-54) / 5.7 g in 1 DOSE PACK (0283-1023-00)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 0283-1023 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0283-1023 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0283-1023. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.